Tech Center 1600 • Art Units: 1634 1683
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17911633 | COMPOSITIONS AND METHODS OF TREATING GLIOMA | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18132298 | METHODS AND COMPOSITIONS FOR LIGATION AND SAMPLE ANALYSIS | Non-Final OA | 10x Genomics, Inc. |
| 18009093 | METHODS FOR SPATIAL ANALYSIS USING BLOCKER OLIGONUCLEOTIDES | Non-Final OA | 10x Genomics, Inc. |
| 17812075 | METHODS FOR SAMPLE TRANSFER FOR IN SITU ANALYSIS | Final Rejection | 10x Genomics, Inc. |
| 18074369 | METHOD OF MAPPING SPATIAL DISTRIBUTIONS OF CELLULAR COMPONENTS | Non-Final OA | CALIFORNIA INSTITUTE OF TECHNOLOGY |
| 17930961 | VECTOR SET FOR MEASURING TRANSPOSASE ACTIVITY, KIT, TRANSPOSASE ACTIVITY MEASURING METHOD, AND CELL SEPARATION METHOD | Final Rejection | KABUSHIKI KAISHA TOSHIBA |
| 16739866 | FUNCTIONAL ANALYSIS OF CANCER CELLS | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 17975384 | CONSECUTIVE HYBRIDIZATION FOR MULTIPLEXED ANALYSIS OF BIOLOGICAL SAMPLES | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17636582 | COMPOSITIONS AND METHODS FOR AMPLIFICATION OF STR LOCI | Non-Final OA | QIAGEN GMBH |
| 17051310 | LYSIS METHOD FOR PLANT SAMPLES | Non-Final OA | QIAGEN GmbH |
| 13703309 | METHOD FOR DETERMINATION OF TARGET CELLS OR TISSUE FOR EXTRACTION OF BIOMOLECULES FROM FIXED BIOLOGICAL SAMPLES | Final Rejection | QIAGEN GMBH |
| 18249597 | A SCREENING PLATFORM FOR ADAR-RECRUITING GUIDE RNAS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 14281212 | SAMPLE MULTIPLEXING | Final Rejection | Bio-Rad Laboratories, Inc. |
| 17871702 | PROGRAMMABLE ENZYME-ASSISTED SELECTIVE EXPONENTIAL AMPLIFICATION FOR SENSITIVE DETECTION OF RARE MUTANT ALLELES | Final Rejection | The Trustees of the University of Pennsylvania |
| 15534577 | DETECTION OF TARGET NUCLEIC ACID SEQUENCES USING DIFFERENT DETECTION TEMPERATURES AND REFERENCE VALUES | Final Rejection | SEEGENE, INC. |
| 19010663 | PROCESS FOR MULTI-ANALYSES OF RARE CELLS EXTRACTED OR ISOLATED FROM BIOLOGICAL SAMPLES THROUGH FILTRATION | Final Rejection | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
| 17749858 | UNIVERSAL LAMP ASSAYS FOR DETECTION OF NUCLEIC ACID TARGETS | Non-Final OA | Duke University |
| 17207040 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ARRHYTHMIAS | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 16588208 | DIAGNOSTIC METHODS AND KITS FOR EARLY DETECTION OF OVARIAN CANCER | Non-Final OA | Ramot at Tel-Aviv University Ltd. |
| 17905724 | MAGNETIC SENSOR ARRAYS FOR NUCLEIC ACID SEQUENCING AND METHODS OF MAKING AND USING THEM | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 17865159 | Set of Oligonucleotide Probes as Well as Methods and Uses Thereto | Non-Final OA | Roche Molecular Systems, Inc. |
| 16786647 | SIGNALING CONJUGATES AND METHODS OF USE | Non-Final OA | VENTANA MEDICAL SYSTEMS, INC. |
| 17931360 | Identifying Feline Renal Risk Factors and Compositions and Methods for Improving Feline Health | Final Rejection | Hill's Pet Nutrition, Inc. |
| 17297859 | TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION | Non-Final OA | KEYGENE N.V. |
| 17564592 | METHOD AND SYSTEM EMPLOYING DISTINGUISHABLE POLYMERASES FOR DETECTING TERNARY COMPLEXES AND IDENTIFYING COGNATE NUCLEOTIDES | Non-Final OA | Pacific Biosciences of California, Inc. |
| 17913679 | METHOD FOR DETECTING TARGET NUCLEIC ACID | Final Rejection | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
| 17930513 | METHOD FOR DETECTING SENSE AND ANTISENSE STRANDS IN AN OLIGONUCLEOTIDE DUPLEX | Non-Final OA | Meso Scale Technologies, LLC. |
| 17948025 | METHOD FOR BIDIRECTIONAL SEQUENCING | Non-Final OA | OXFORD NANOPORE TECHNOLOGIES PLC |
| 18015627 | SYSTEMS AND METHODS FOR CELL CAPTURE, BIOMARKER DETECTION, AND CONTACT-FREE CELL LYSIS | Non-Final OA | Trustees of Dartmouth College |
| 17980848 | Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same | Non-Final OA | Takara Bio USA, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy